As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

Webinar : Biologics by Design

Genopole and Schrödinger invite you to attend a webinar during which Schrödinger will present its modeling platform and the production of biological molecule design.

  • Dr Dan Cannon, Sr. Application Scientist – Schrödinger
  • Sr Valentina Cantatore, Account Manager – Schrödinger

Registration for the webinar is free but compulsory to obtain login information.

>> Sign-up !

At the end of the presentation, we will host a virtual coffee break with different breakout rooms. During this break, you can discuss your own research challenges and understand how the Schrödinger platform can improve your discovery process.

Logo Schrödinger

April 8, 2021

11:00 – 12:00 Webinar
12:00 – 12:30 virtual coffee break


Biologics are one of the most important classes of therapeutics, despite this, application of rational design strategies remains challenging.
Recently, in silico technologies have emerged as valuable tools for designing and optimizing biologics. In this webinar, we will show how accurate and reliable computational solutions can be applied during research and development to direct experimental effort, subsequently reducing costs and timelines.
Through the Schrödinger design platform, we will demonstrate the value of such techniques towards typical rational design challenges, including protein stability engineering, enzyme design, antibody optimization or protein formulation and aggregation prediction.

With the support from
Région île de France